Powder: -20℃ for 3 years. In solvent: -80℃ for 1 year.
Synonyms
MDV3100
Description
Enzalutamide (MDV3100) is an androgen receptor (AR) antagonist (IC50=36 nM in LNCaP) that activates autophagy, exhibits antitumor activity, and is commonly used in treating desmoplasia-resistant prostate cancer.